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Abstract
Objective
Limited evidence concerning the burden and predictors of omitted medication doses within
mental health hospitals could severely limit improvement efforts in this specialist setting.
This study aimed to determine the prevalence, nature and predictors of omitted medication
doses affecting hospital inpatients in two English National Health Service (NHS) mental
health trusts.
Methods
Over 6 data collection days trained pharmacy teams screened inpatient prescription charts
for scheduled and omitted medication doses within 27 adult and elderly wards across 9 psy-
chiatric hospitals. Data were collected for inpatients admitted up to two weeks prior to each
data collection day. Omitted doses were classified as ‘time critical’ and ‘preventable’ based
on established criteria. Omitted dose frequencies were presented with 95% confidence
intervals (CI). Multilevel logistic regression analyses determined the predictors of omitted
dose occurrence, with omission risks presented as adjusted odds ratios (OR) with 95% CI.
Results
18,664 scheduled medication doses were screened for 444 inpatients and 2,717 omissions
were identified, resulting in a rate of 14.6% (95% CI 14.1–15.1). The rate of ‘time critical’
omitted doses was 19.3% (95% CI 16.3–22.6%). ‘Preventable’ omitted doses comprised
one third of all omissions (34.5%, 930/2694). Logistic regression analysis revealed that
medicines affecting the central nervous system were 55% less likely to be omitted compared
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to all other medication classes (9.9% vs. 18.8%, OR 0.45 (0.40–0.52)) and that scheduled
doses administered using non-oral routes were more likely to be omitted compared the oral
route (inhaled OR 3.47 (2.64–4.57), topical 2.71 (2.11–3.46), ‘other’ 2.15 (1.19–3.90)). ‘Pre-
ventable’ dose omissions were more than twice as likely to occur for ‘time critical’ medica-
tions than non-time critical medications (50.4% vs. 33.8%, OR 2.24 (1.22–4.11)).
Conclusions
Omitted medication doses occur commonly in mental health hospitals with ‘preventable’
omissions a key contributor to this burden. Important targets for remedial intervention have
been identified.
Introduction
Ensuring that medicines are managed appropriately is essential to facilitate the ongoing treat-
ment and recovery for many patients with mental health problems [1]. Within the mental
health hospital setting, there are a number of unique factors which could influence the quality
and safety of medicines management processes including the health care system (e.g. presence
of medicines reconciliation [2], mental health legislation [3], and drug administration prac-
tices [4, 5]), medicines used (e.g. high risk drug monitoring [6, 7], high dose/combination psy-
chotropic prescribing [8]) and patient population (e.g. high physical health co-morbidity [9],
limited insight into illness and disturbed/withdrawn behaviours [10]).
Unsafe use of medicines has recently been highlighted as a chief cause of preventable harm
in health care worldwide [11], with the World Health Organisation (WHO) making under-
standing and improving medication-related harm a global priority in 2017 [12]. Within psy-
chiatric hospitals, international evidence suggests that patients are frequently placed at risk
from medication errors and their adverse consequences [13], with medication administration
errors (MAE) one of the most common error types [13–16]. The origins of many MAEs are
multifactorial, with important differences to general hospitals [10, 17].
Studies investigating the burden of MAEs in mental health hospitals consistently highlight
omitted medication doses as among the most frequently observed or reported MAEs [17–19].
Omitted doses are those that are prescribed but not administered and the risk they pose to
patient safety was highlighted in a patient safety alert issued in 2010 which described 183 cases
of harm resulting from delayed or omitted dose incidents (n = 21,383) reported across England
and Wales between September 2006 –June 2009. However, only 6.3% of the total reports origi-
nated from psychiatric settings [20].
Whilst more general studies of MAEs across mental health and general hospitals may pro-
vide data concerning the overall frequency of omitted doses, they do not contain sufficient
detail to understand their nature (e.g. medications involved and underlying reasons especially
unavailable drugs or ‘blank boxes’ not signed for administration which may be preventable) or
predicting factors [13, 21]. More in-depth investigations focusing on omitted doses have
helped address these needs in general hospitals including highlighting the a significant propor-
tion of potentially ‘preventable’ omissions [22–24], but this data may not be generalizable to
mental health hospitals and the evidence base in psychiatry is largely absent except for two sin-
gle site UK studies restricted to reported missing signatures for medicines administration [25]
and overall omitted dose rates within elderly care [26]. This highlights a need for further
research across multiple mental health hospitals that explores in detail the type, preventability
Burden and predictors of omitted doses in psychiatric hospitals
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and predictors of omissions to guide development of remedial interventions. This study there-
fore aimed to determine the prevalence, nature and predictors of omitted medication doses
affecting inpatients in two English mental health NHS trusts.
Methods
Definitions
We defined an omitted medication dose as ‘a dose of prescribed medication that is not admin-
istered before the next dose is due’ [23]. ‘Preventable’ omitted doses were defined as those
without a reason for omission specified on the patient’s medication chart, or with a reason due
to unavailability of medication at the time of administration [27]. The remaining categories of
dose omission considered to be ‘non-preventable’ were patient refusal, omission for a clinical
reason/prescriber direction, patient asleep or ‘other’. ‘Time critical’ doses were defined as
those which carry an increased risk of patient harm if a single dose is omitted, and included
any of the following based on established criteria [20]: insulin, Parkinson’s disease medica-
tions, anti-infective medications (excluding topical formulations), and anti-coagulants.
Setting
This study was conducted across 9 hospitals containing 27 acute adult and elderly wards within
two English mental health NHS trusts. Specialist wards such as long-stay forensics, intensive
care and child and adolescent care were excluded. A total of 11 hospitals were managed by the
trusts, with 1 excluded from the study as it contained long stay forensic units and the other
due to local resource constraints. Both trusts utilised inpatient paper prescription and medica-
tion administration charts. The study sites each employed pharmacy teams to perform ward
duties including medicines supply, medicines reconciliation and medication related advice.
Medication supplies were co-ordinated utilising on-site or off-site dispensary services. Nursing
staff administered medications to patients during 4 scheduled rounds (morning, lunchtime,
early evening, night time). With the exception of elderly units, patients were required to attend
the ward clinic/treatment room to receive their medications. Across all wards and particularly
on the elderly units, ‘runners’ (usually trained health care assistants or nurses) were frequently
utilised to bring patients to the clinic room or to take medications directly to patients for
administration [4]. In order to record drug administration activity, nurses initialled a box on
the prescription chart specific for particular doses, and the date/time they successfully admin-
istered it; if the dose was omitted for any reason the nurse was instructed to enter a code per-
taining to the reason for the dose omission.
Data collection
Data were collected on 6 pre-arranged data collection days between September–December
2015. The number of data collection days was chosen based on local NHS trust capacity and
were scheduled to ensure data were collected over a 3 month period to better reflect usual
working practices. Data collection days took place on weekdays separated by at least 2 weeks to
ensure no duplication of data. Both pharmacists and pharmacy technicians could collect data.
Paper inpatient prescription charts were screened for all patients on the eligible wards who
were prescribed at least one regular medication and were admitted up to 14 days prior to each
data collection day. This meant that a maximum of 14 days’ worth of scheduled doses could be
collected per patient. Patients transferred from other NHS organisations were considered new
admissions, whereas internal NHS trust patient transfers were considered continuous
admissions.
Burden and predictors of omitted doses in psychiatric hospitals
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Data collection included all scheduled and omitted doses due at any time of day or any day
of the week during each patient’s screening period. Eligible medications were any listed in the
British National Formulary (BNF) [28]. Information recorded included ward type (adult/
elderly), patient age/gender, medication names/forms/routes, weekend or weekday, medica-
tion round, and reason for any dose omissions. As required (pro re nata) medication doses
were excluded, as were any medication doses scheduled when the patient was temporarily off
the ward (e.g. periods of leave). Only regular and ‘stat’ once only prescriptions active on the
day of data collection were considered eligible for inclusion in the study; previously cancelled
prescription items were excluded. Pharmacy teams examined re-written prescription charts to
confirm patient eligibility and screen 14 days’ worth of data.
Standardised training for pharmacist and pharmacy technician data collectors employed by
the study sites involved a face-to-face seminar including an introduction to the study and guid-
ance with completing the data collection forms. A data collection guidebook was also made
available throughout the study and teams could contact the researchers with queries.
Data analysis
Data were collated and entered into a Microsoft Excel1 database by RNK, KB and GHA. Data
analysis proceeded using STATA v151. Descriptive statistics were employed to determine the
point prevalence and nature of omitted doses. Rates of total omitted dose, ‘preventable’ omit-
ted doses, and total/’preventable’ omitted doses involving ‘time critical’ medications were cal-
culated by dividing the total number of relevant omitted doses by the total number of eligible
scheduled doses and were presented using frequencies and 95% confidence intervals (CI).
Adjusted outcome rates were also presented for total and ‘time critical’ doses based on the
hierarchical structure of the data.
Mixed effects logistic regression modelling was conducted to determine potential associa-
tions between total and ‘preventable’ omitted dose outcomes and covariates. The analyses
accounted for the multi-level data structure, with doses nested within patients and patients
nested within wards. Individual hospitals and NHS trusts were treated as fixed effects in the
model. Given the complexity of the data structure, each potential covariate was considered, in
turn, in a series of univariable models. Co-variates included ward type, day of week, medica-
tion round, administration route, medication class, ‘time critical’ medication, patient age and
gender. Covariates with a p-value of<0.2 were included in a multivariable model. Non-signifi-
cant (p>0.05) covariates were then removed, one at a time, leaving the most parsimonious
model. Adjusted odds ratios (ORs) and 95% confidence intervals are presented to give context
to the findings, with p<0.05 used to express statistical significance.
Ethical approval
The study was approved by The University of Manchester Research Ethics Committee 5 (sub-
mission 15326) and by the audit departments at each participating NHS trust. Data were fully
pseudonymised by data collectors before being sent to the research team; no patient identifi-
able data was accessible during analysis. Individual patient consent was not required by the
research ethics committee for this retrospective service evaluation study.
Results
A total of 18,664 scheduled medication doses were screened across 6 data collection days.
These doses were intended for 444 inpatients residing on 27 wards, with the range of individ-
ual scheduled doses per ward and per patient reported as 134–1474 (mean 691) and 1–298
(mean 42), respectively.
Burden and predictors of omitted doses in psychiatric hospitals
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Total omitted doses
Pharmacy teams identified 2,717 omissions with a resulting crude omission rate of 14.6%
(95% CI 14.1–15.1) of scheduled doses. After adjusting for clustering of dose omissions within
individual patients, the omitted dose rate was 8.7% (95% CI 6.41–11.77%). Variability in omit-
ted dose rates was observed across patient age, route of administration, medication round and
therapeutic drug groups, with ‘skin’ having the highest omission rate (BNF Chapter 13, 120/
314, 38.2%) and ‘central nervous system’ having a lower rate (9.9%, 890/8,951). There was also
a large difference in omission rate between the lunchtime and night time medication rounds
(20.0%, (313/1,562) vs. 12.5% (719/5,769)). The oral route of administration had the largest
proportion of scheduled doses (92%) but the lowest omitted dose rate (13.3%, 2,287/17,160),
with inhaled route more than double this (28.9%, 200/691). The rate of overall omissions
including various subcategories is summarised in Table 1.
‘Time critical’ total omissions. Of the 18,664 scheduled doses, 637 were considered to be
‘time critical’. A total of 123 of these were identified as omissions, giving a crude ‘time critical’
omission rate of 19.3% (95% CI 16.3–22.6%); the corresponding adjusted rate was 13.6% (95%
CI 4.8–33.3%). The majority of administrations in this category were for oral medication (528/
637, omission rate 21.8%; ‘other’ route 8/109, 7.3%). Male patients had an omission rate more
than twice that of females (28.7% (86/300) vs. 11.0% (37/337)). Please see Table 2 for more
details.
‘Preventable’ omitted doses
Of the 2,717 omitted doses recorded, 23 did not have a ‘reason’ specified leaving 2,694 which
could be considered ‘preventable’ or ‘non-preventable’. Following categorisation, a total of
34.5% (930/2694) were considered to be ‘preventable’. Of these, the majority (58.1%, 540/930)
were classified as ‘unavailable drug’. The remaining ‘non-preventable’ omitted doses were
most commonly patient refusal (1550/1764, 87.9%). Preventable doses are summarised in
Tables 1, 2 and 3.
The topical and inhaled routes of drug administration had ‘preventable’ omitted dose rates
more than triple that of the oral route (topical 14.7% (96/652); inhaled 15.5% (106/683); oral
4.2% (722/17,148)). The night time medication round was associated with an omission rate
nearly half that of the early evening round (3.8% (219/5,764) vs. 6.9% (157/2,271)). The rate of
‘time critical’ ‘preventable’ dose omissions was twice that of ‘non-time critical’ omissions
(9.7% (62/637) vs. 4.8% (868/18,004)). See Table 1 for more details.
‘Time critical’ preventable omissions. Half of all ‘time critical’ dose omissions were
recorded as ‘preventable’ (62/123, 50.4%). Of these, the vast majority (64.5%, 40/62) were
‘unavailable drug’. See Tables 2 and 3.
Predictors of omitted doses
Multivariate analysis–total omitted doses. Multivariate analysis revealed that, compared
to the morning medication administration round, the lunchtime (OR 1.58 (1.33, 1.88)) and
early evening rounds (OR 1.24 (1.06, 1.45), both p<0.001) were associated with a statistically
significant higher risk of any dose omission (there was no difference for night time rounds
(OR 0.92 (0.81, 1.04)). In respect to administration route; compared to oral the topical (OR
2.71 (2.11, 3.46)), inhaled (OR 3.47 (2.64, 4.57)) and ‘other’ (including injectable, OR 2.15
(1.19, 3.90)) routes were all significantly associated with increased dose omission risk (all
p<0.001). In contrast, the ‘central nervous system’ BNF chapter was associated with a 55%
lower risk of omitted doses than all other chapters combined (OR 0.45 (0.40, 0.52), p<0.001).
No significant associations were identified in univariate analysis for ward type, day of the
Burden and predictors of omitted doses in psychiatric hospitals
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Table 1. Crude rate of total and ‘preventable’ omitted doses across subcategories.
Category Percentage (%) crude rate for total omitted doses (numerator
/ denominator)
Percentage (%) crude rate for ‘preventable’ omitted doses
(numerator / denominator)
BNF1: Gastrointestinal
System
15.8% (267/1,688) 3.9% (65/1,686)
BNF2: Cardiovascular
System
15.8% (347/2,198) 6.6% (144/2,195)
BNF3: Respiratory System 22.3% (197/883) 12.9% (113/875)
BNF4: Central Nervous
System
9.9% (890/8,951) 2.8% (248/8,950)
BNF5: Infection 27.2% (108/397) 14.7% (58/395)
BNF6: Endocrine System 17.4% (158/910) 5.5% (50/910)
BNF7: Genito-urinary
System
19.5% (30/154) 10.4% (16/154)
BNF8: Immune /
Malignancy
3.3% (1/30) 3.3% (1/30)
BNF9: Blood and Nutrition 18.7% (513/2,744) 5.2% (143/2,738)
BNF10: Musculoskeletal 8.3% (8/97) 5.2% (5/97)
BNF11: Eye 25.9% (42/162) 9.3% (15/162)
BNF12: Ear, Nose,
Oropharynx
26.5% (36/136) 17.8% (24/135)
BNF13: Skin 38.2% (120/314) 15.3% (48/314)
Total 18,664 18,641�
Oral route 13.3% (2,287/17,160) 4.2% (722/17,148)
Topical route 28.5% (224/786) 14.7% (96/652)
Inhaled route 28.9% (200/691) 15.5% (106/683)
Other route�� 22.2% (6/27) 3.8% (6/158)
Total 18,664 18,641�
Morning round 14.5% (1,315/9,058) 5.0% (452/9,045)
Lunchtime round 20.0% (313/1,562) 6.5% (102/1,561)
Early evening round 16.3% (370/2,275) 6.9% (157/2,271)
Bedtime round 12.5% (719/5,769) 3.8% (219/5,764)
Total 18,664 18,641�
Adult ward 13.9% (1,935/13,931) 5.2% (719/13,913)
Elderly ward 16.5% (782/4,733) 4.5% (211/4,728)
Total 18,664 18,641�
Male patients 11.5% (955/8,290) 4.0% (335/8,277)
Female patients 17.0% (1,762/10,374) 5.7% (595/10,364)
Total 18,664 18,641�
Patient age between 18–34 14.8% (489/3,316) 5.6% (184/3,312)
Patient age between 35–44 9.8% (387/3,935) 3.7% (145/3,933)
Patient age between 45–54 15.3% (487/3,175) 5.7% (181/3,169)
Patient age between 55–64 13.3% (265/1,987) 6.2% (124/1,987)
Patient age between 65–74 15.4% (520/3,369) 3.6% (121/3,361)
Patient age between 75–94 19.7% (569/2,882) 6.1% (175/2,879)
Total 18,664 18,641�
Weekday doses 14.7% (2,125/14,436) 4.8% (698/14,421)
Weekend doses 14.0% (592/4,228) 5.5% (232/4,220)
Total 18,664 18,641�
‘Time critical’ dose 19.3% (123/637) 9.7% (62/637)
‘Non time critical’ dose 14.3% (2,571/18,027) 4.8% (868/18,004)
(Continued)
Burden and predictors of omitted doses in psychiatric hospitals
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week, patient age, patient gender and ‘time critical’ medications were not taken forward to
multi-variate analysis. Details of the predictor analysis for total omitted doses are presented in
Table 4.
Multivariate analysis–‘preventable’ omitted doses. Compared with ‘non-preventable’
omissions, ‘preventable’ omitted doses were reported to be twice as likely to occur with ‘time
critical’ doses than ‘non-time critical’ doses (OR 2.24 (1.22–4.11), p = 0.01). ‘Preventable’ dose
omissions were 46% more likely to occur than ‘non-preventable’ omissions for the early even-
ing medication round (OR 1.46 (1.01–2.12), p<0.001, compared to morning) and were 37%
Table 1. (Continued)
Category Percentage (%) crude rate for total omitted doses (numerator
/ denominator)
Percentage (%) crude rate for ‘preventable’ omitted doses
(numerator / denominator)
Total 18,664 18,641�
BNF: British National Formulary [28] � Excludes 23 doses without reason for omission specified �� Includes injections
https://doi.org/10.1371/journal.pone.0228868.t001
Table 2. Crude rate of ‘time critical’ medication omissions across subcategories.
Category Percentage (%) crude rate (numerator & denominator)
Total omitted doses ‘Preventable’ omitted doses
Oral route 21.8% (115/528) 50.4% (58/115)
Topical route 0% (0/0) 0% (0/0)
Inhaled route 0% (0/0) 0% (0/0)
Other route� 7.3% (8/109) 50.0% (4/8)
Total 637 123��
Morning round 20.2% (58/287) 51.7% (30/58)
Lunchtime round 31.0% (22/71) 63.6% (14/22)
Early evening round 12.1% (17/141) 47.1% (8/17)
Bedtime round 18.8% (26/138) 38.5% (10/26)
Total 637 123��
Adult ward 19.1% (82/430) 68.3% (56/82)
Elderly ward 19.8% (41/207) 14.6% (6/41)
Total 637 123��
Male patients 28.7% (86/300) 50.0% (43/86)
Female patients 11.0% (37/337) 51.4% (19/37)
Total 637 123��
Patient age between 18–34 31.6% (43/136) 67.4% (29/43)
Patient age between 35–44 3.5% (6/171) 100% (6/6)
Patient age between 45–54 46.4% (26/56) 76.9% (20/26)
Patient age between 55–64 4.8% (1/21) 0% (0/1)
Patient age between 65–74 16.9% (20/118) 10.0% (2/20)
Patient age between 75–94 20.0% (27/135) 18.5% (5/27)
Total 637 123��
Weekday doses 20.8% (104/499) 51.9% (54/104)
Weekend doses 13.8% (19/138) 42.1% (8/19)
Total 637 123��
� Includes: injectable medication
�� Excludes doses without a reason specified
https://doi.org/10.1371/journal.pone.0228868.t002
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less likely for the night time medication round (OR 0.63 (0.46–0.86), p<0.001). The inhaled
route of administration (OR 1.83 (1.06–3.16), compared to oral) was found to be more likely
to be associated with ‘preventable’ rather than ‘non-preventable’ dose omissions (p<0.01),
with the ‘other’ administration route 85% less likely to be associated with ‘preventable’ than
‘non-preventable’ omissions (OR 0.15 (0.04–0.58), p = 0.006). Patients residing on elderly
wards were 74% less likely to experience a ‘preventable’ omission compared to a ‘non-prevent-
able’ omission compared to those on adult wards (OR 0.26 (0.08–0.79), p = 0.018), and ‘pre-
ventable’ omissions were more than three times more likely on weekends compared to
Table 3. Frequency of omitted dose reasons by category.
Category Frequency (%)
‘Non-preventable’ omitted doses ‘Preventable’ omitted doses Total
Clinical reason Patient refusal Patient asleep Other Unavailable drug Not signed
All omitted doses 100 (3.7) 1550 (57.5) 70 (2.6) 44 (1.6) 540 (20.0) 390 (14.5) 2694 (100)
‘Time critical’ omitted doses 2 (1.6) 55 (44.7) 3 (2.4) 1 (0.8) 40 (32.5) 22 (17.9) 123 (100)
https://doi.org/10.1371/journal.pone.0228868.t003
Table 4. Univariable and Multivariable Associations from Logistic Regression Analyses of Total Omitted Doses on Patient-, Drug/ Dose- and Ward-Specific
Covariates.
Covariate Category Odds Ratios for Associations between Omitted Dose and Covariates
Univariable Multivariable
Coefficient
(95% C.I.)
p-value Coefficient
(95% C.I.)
p-value
Ward Type Adult Reference 0.025 NS
Elderly 2.01 (1.09, 3.71)
Day of the Week Weekday Reference 0.215 NS
Weekend 1.08 (0.96, 1.22)
Medicines Administration Round Morning Reference <0.001 Reference <0.001
Lunchtime 1.49 (1.26, 1.77) 1.58 (1.33, 1.88)
Early Evening 1.24 (1.06, 1.45) 1.24 (1.06, 1.45)
Night Time 0.82 (0.72, 0.92) 0.92 (0.81, 1.04)
Administration Route Oral Reference <0.001 Reference <0.001
Inhaled 4.60 (3.53, 5.99) 3.47 (2.64, 4.57)
Topical 3.77 (2.97, 4.79) 2.71 (2.11, 3.46)
Other 2.71 (1.52, 4.85) 2.15 (1.19, 3.90)
Medication Class Non-Central Nervous System Reference <0.001 Reference <0.001
Central Nervous System 0.38 (0.33, 0.42) 0.45 (0.40, 0.52)
Time Critical Medication Not Time Critical Reference 0.005 NS
Time Critical 1.56 (1.14, 2.13)
Patient Age-Group 18–34 Reference 0.001 NS
35–44 0.78 (0.42, 1.44)
45–54 1.41 (0.74, 2.69)
55–64 1.71 (0.82, 3.57)
65–74 1.87 (0.91, 3.85)
75–94 4.04 (1.93, 8.44)
Patient Gender Male Reference 0.116 NS
Female 0.71 (0.46, 1.09)
NS. Covariate was not statistically significant at the 5% level (i.e. p>0.05).
https://doi.org/10.1371/journal.pone.0228868.t004
Burden and predictors of omitted doses in psychiatric hospitals
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weekdays (OR 3.44 (2.51–4.72), p<0.001). The topical route and lunchtime medication rounds
showed no significant association in multivariate analysis, and patient age, gender and medica-
tion class did not progress from univariate modelling. For full details of predictor analysis
please see Table 5.
Discussion
This is the first study to explore the prevalence, nature and predictors of omitted doses of med-
ication across multiple mental health hospitals. Our findings suggest that omitted doses are
common in this setting with a third considered to be ‘preventable’. We found evidence that
doses for medications designed to treat conditions outside the central nervous system (CNS)
appeared more likely to be omitted than those for CNS drugs. ‘Preventable’ omissions were
twice as likely to affect ‘time critical’ than non-‘time critical’ doses, affected patients residing
on elderly wards less frequently and were three times as likely to occur on weekends. Non-oral
routes of administration also emerged as an important predictor for omitted doses across both
overall and ‘preventable’ omitted doses.
Table 5. Univariable and Multivariable Associations from Logistic Regression Analyses of ‘Preventable’ Omitted Doses on Patient-, Drug/ Dose- and Ward-Specific
Covariates.
Covariate Category Odds Ratios for Associations between ‘Preventable’ Omitted Dose and
Covariates
Univariable Multivariable
Coefficient
(95% C.I.)
p-value Coefficient
(95% C.I.)
p-value
Ward Type Adult Reference 0.028 Reference 0.018
Elderly 0.30 (0.10, 0.88) 0.26 (0.08, 0.79)
Day of the Week Weekday Reference <0.001 Reference <0.001
Weekend 3.47 (2.53, 4.74) 3.44 (2.51, 4.72)
Medicines Administration Round Morning Reference <0.001 Reference <0.001
Lunchtime 1.10 (0.75, 1.63) 1.05 (0.71, 1.57)
Early Evening 1.48 (1.03, 2.13) 1.46 (1.01, 2.12)
Night Time 0.65 (0.48, 0.88) 0.63 (0.46, 0.86)
Administration Route Oral Reference 0.057 Reference 0.006
Inhaled 1.51 (0.90, 2.55) 1.83 (1.06, 3.16)
Topical 1.06 (0.63, 1.77) 1.03 (0.60, 1.76)
Other 0.26 (0.08, 0.88) 0.15 (0.04, 0.58)
Medication Class Non-Central Nervous System Reference 0.111 NS
Central Nervous System 0.78 (0.58, 1.06)
Time Critical Medication Not Time Critical Reference 0.065 Reference 0.010
Time Critical 1.69 (0.97, 2.96) 2.24 (1.22, 4.11)
Patient Age-Group 18–34 Reference 0.981 NS
35–44 0.88 (0.25, 3.02)
45–54 0.65 (0.18, 2.34)
55–64 0.84 (0.21, 3.38)
65–74 0.68 (0.17, 2.65)
75–94 0.65 (0.17, 2.48)
Patient Gender Male Reference 0.377 NS
Female
NS. Covariate was not statistically significant at the 5% level (i.e. p>0.05).
https://doi.org/10.1371/journal.pone.0228868.t005
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Implications of findings
Medication errors are currently of global interest, with recent evidence highlighting their
major role in causing preventable harm in health care [11]. Our findings help respond to the
WHO Global Patient Safety Challenge ‘Medication Without Harm’ agenda by identifying
medication, patient and system factors associated with omitted dose and in particular ‘prevent-
able’ omitted dose risk, which informs targeted interventions under the ‘high-risk situations’
priority for action [12].
Limited progress has been made in mental health settings to routinely monitor omitted
doses, openly share and benchmark data, and then work towards reducing their burden as
part of quality improvement efforts [26, 29]. Our study findings support recommendations
[30, 31] for increased attention to using meaningful, routinely collected and accessible data
such as this as part of quality improvement efforts, with a focus on ‘preventable’ omissions to
drive local improvement efforts.
‘Preventable’ dose omissions have emerged as an important target for remedial intervention
in this research. The ratio of ‘preventable’ to ‘non-preventable’ omissions that we observed
appears broadly similar to data from general hospital studies [23, 24, 27]. Available evidence
for the causes of unavailable drug related ‘preventable’ omitted doses from mental health hos-
pitals [14–16] identifies causative factors such as medicines logistics, but detail is often limited
to codes on prescription charts or brief descriptions in incident reports. Further in-depth
investigation is therefore required as seen elsewhere for general MAEs [10] to help inform
interventions tailored to the mental health setting.
Our finding that medications within the CNS class (containing all psychotropic drugs) had
a lower risk of being omitted than those from other classes was perhaps not surprising given
the specialist psychiatric setting for this study. Indeed, a greater proportion of non-psychotro-
pic drugs were found to be affected by MAEs than psychotropics in one UK based MAE study
on two long stay older person psychiatric wards [18]. However, this relationship was not pres-
ent for ‘preventable’ omissions compared to ‘non-preventable’ and indicates that health pro-
viders could focus attention on supporting patients and staff to reduce refusal of medication in
clinical practice as this was the most common reason for ‘non-preventable’ omissions. A nar-
rative literature review study published in 2011 helps to identify the implications and factors
associated with inpatient medication refusal in psychiatry to guide local improvement efforts,
but further research is required to explore the aetiology of dose refusals to inform this activity
[32].
Medication doses administered using non-oral routes were consistently associated with at
least two fold risk of overall (and ‘preventable’ for inhaled doses) omissions compared to the
oral administration route. One other published study of MAEs in mental health hospitals con-
ducted a similar comparison, finding that a greater proportion of errors involved non-oral
administration routes on two elderly units [18]. Targeted investigation into the causes of this
observation could include exploration of variable practices of medication storage (noted to be
a causative factor in some types of MAE in psychiatry [9]) and awareness and training of spe-
cialist mental health staff in physical health illnesses which has been previously highlighted as
an area for development for nurses, for example [33, 34].
Our finding that the rate of omissions of ‘time critical’ medication doses was higher than
overall scheduled doses, and that these omissions were twice as likely to affect ‘preventable’
omitted doses compared to non-time critical doses is concerning in light of the high risk of
patient harm these medications are known to pose, with a UK national alert issued 10 years
ago [20]. This should instigate renewed and prompt action within wider mental health care
organisations to thoroughly and routinely investigate the burden and causes of this issue in
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order to develop effective and sustainable solutions. In one example, researchers from Austra-
lia described the successful development and implementation of a ‘time-critical’ medication
identification and audit tool in 11 hospitals, with staff finding the tool useful to inform
improvement efforts [35]. When considered alongside our finding that ‘preventable’ omissions
were three times more likely to occur at weekends than weekdays compared to ‘non-prevent-
able’ omissions, this highlights the need for health providers to review medicines supply proce-
dures at weekends such as provision of emergency drug cupboards and input of pharmacy
services. In recent years, general hospitals in the UK have seen the introduction of twenty-four
hour pharmacy services in order to improve safety including dose omissions [36, 37].
As one of the most commonly occurring MAEs, omitted doses have been the subject of
improvement interventions in general hospitals targeting pharmacy staff/systems [27, 38],
nursing education, information technology and error reporting schemes [39], some with
mixed results. The evidence base in psychiatry requires expansion as it is limited to a national
UK benchmarking initiative [29], and two positive single site studies of awareness/benchmark-
ing [26] and automated dispensing cabinets [40]. The introduction of electronic prescribing
and medication administration (EPMA) systems may be expected to reduce certain omitted
doses (e.g. prescription not signed for administration), and the two participating mental health
trusts in this study are currently working towards implementation. However, evidence from
general hospitals indicates that ‘preventable’ omissions may persist despite the use of EPMA
[41, 42].
Strengths and limitations
Important strengths of this study include data collection taking place across 9 hospitals within
two large NHS trusts, the use of standardised training across participating sites, adoption of a
design which minimised double counting of scheduled/omitted doses and the exploration of a
number of risk factors for both overall and ‘preventable’ omitted doses. However, it is impossi-
ble to rule out variations in data collection between pharmacy teams, and our study sites were
confined to one geographical region in England which could limit generalisability.
Our data collection process was designed to balance the retrieval of optimal omitted dose
data against limited pharmacy team capacity. As such, we were not able to collect data beyond
2 weeks’ hospital stay for each eligible patient, nor were we able to collect data on any medica-
tions that may have been prescribed during this period but were not ‘active’ on the data collec-
tion day. In order to maximise generalisability of our findings, we excluded specialist wards
such as intensive care and child/adolescent care and future work should determine if omitted
dose rates differ on these units. Whilst we could not determine the actual/potential severity of
recorded omitted doses, by including ‘time critical’ medications we were able to assign clinical
meaning to our findings. Whilst some may not include certain types of omissions such as
doses refused/omitted for clinical reasons as omitted doses [43], they were included in this
study and we separated data for ‘preventable’ omitted doses. It is also theoretically possible for
some omitted doses considered to be ‘non-preventable’ to actually be ‘preventable’ (e.g. patient
refuses due to correctable lack of understanding of medication). However, confirmation
would require extensive investigation in the clinical setting and was beyond the resource capa-
bilities for many data collection teams.
Conclusion
This is the first in-depth exploration of the prevalence, nature and predictors of omitted doses
in mental health hospitals. Omissions were recorded for approximately 1 in 7 scheduled doses,
with similar numbers of ‘time critical’ doses affected. ‘Preventable’ omitted doses emerged as
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an important target for remedial intervention, accounting for more than one third of overall
omitted doses and being twice as likely to affect ‘time critical’ doses than ‘non-time critical’
doses. The findings of this study should be used to inform the development of future research
and quality improvement interventions designed to reduce the burden of omitted doses in psy-
chiatric hospitals.
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